# Pediatric Pharmacokinetic (PK) Study of EXE844 Otic Suspension in Otitis Media at the Time of Tympanostomy Tube Insertion (OMTT)

> **NCT02539654** · PHASE1 · COMPLETED · sponsor: **Alcon Research** · enrollment: 14 (actual)

## Conditions studied

- Otitis Media With Effusion in Children
- Otitis Media Recurrent

## Interventions

- **DRUG:** EXE844 Sterile Otic Suspension, 0.3%
- **PROCEDURE:** Tympanostomy Tube Insertion

## Key facts

- **NCT ID:** NCT02539654
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11-17
- **Primary completion:** 2016-06-24
- **Final completion:** 2016-06-24
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2018-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02539654

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02539654, "Pediatric Pharmacokinetic (PK) Study of EXE844 Otic Suspension in Otitis Media at the Time of Tympanostomy Tube Insertion (OMTT)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02539654. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*